The Technical Analyst
Select Language :
Jubilant Ingrevia Limited [JUBLINGREA.NS]

Exchange: NSE Sector: Healthcare Industry: Biotechnology

Jubilant Ingrevia Limited Price, Forecast, Insider, Ratings, Fundamentals & Signals

Jubilant Ingrevia Limited is listed at the  Exchange

0.15% INR524.00

America/New_York / 8 mai 2024 @ 01:29


Jubilant Ingrevia Limited: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 83 463 mill
EPS: 12.99
P/E: 40.34
Earnings Date: May 14, 2024
SharesOutstanding: 159.28 mill
Avg Daily Volume: 0.862 mill
RATING 2024-05-08
B+
Neutral
RATINGS
Rating CashFlow: Sell
Return On Equity: Neutral
Return On Asset: Neutral
DE: Sell
P/E: Strong Buy
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset n/an/an/a
Debtn/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 40.34 | sector: PE 0
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE 40.34 | industry: PE 0
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

INR 498.82 - 547.98

( +/- 4.70%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 11:08 - INR524.42
Forecast 2: 11:58 - INR522.37
Forecast 3: 12:38 - INR524.73
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price INR524.00 (0.15% )
Volume 0.0611 mill
Avg. Vol. 0.862 mill
% of Avg. Vol 7.09 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Jubilant Ingrevia Limited

Last 12 Months

Last 12 months chart data with high, low, open and close for Jubilant Ingrevia Limited

RSI

Intraday RSI14 chart for Jubilant Ingrevia Limited

Last 10 Buy & Sell Signals For JUBLINGREA.NS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Jubilant Ingrevia Limited

JUBLINGREA.NS

Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.

Last 10 Buy Signals

Date Signal @
YF-DAIUSDMay 8 - 01:2537.91
PAXGUSDMay 8 - 01:272 280.00
PROUSDMay 8 - 01:26$2.63
LEOUSDMay 8 - 01:255.86
AQTUSDMay 8 - 01:251.340
ATORUSDMay 8 - 01:202.13
VRXUSDMay 8 - 01:1849.91
WBTCUSDMay 8 - 01:1561 065
MPLUSDMay 8 - 01:1513.96
CTXUSDMay 8 - 01:154.57

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.